Figures
In Table 3, the number of CVD cases in the non-denosumab group should be corrected from “3 (1.9)” to “32 (19.8)”. Please see the correct Table 3 here.
Reference
Citation: Kobayashi A, Yaginuma T, Kato K, Nakashima A, Ohkido I, Yokoo T (2025) Correction: Effect of denosumab on the incidence of fractures and mortality in patients undergoing hemodialysis: A retrospective cohort study. PLoS ONE 20(3): e0320569. https://doi.org/10.1371/journal.pone.0320569
Published: March 21, 2025
Copyright: © 2025 Kobayashi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.